BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 27, 2007
View Archived Issues
Genzyme rounds up recent pipeline developments
Read More
New treatment options for hepatitis C described in recent patents
Read More
Novel analgesic agents imparted in recent Merck patent
Read More
AM-101 begins phase I/II study for tinnitus
Read More
Enrollment closes in phase II Bronchitol study in cystic fibrosis
Read More
Kuros' solitary bone cyst product awarded U.S. orphan drug status
Read More
Celebrex label extended to include ankylosing spondylitis in E.U.
Read More
Chimerix closes Series D financing
Read More
Pro-Pharmaceuticals to discuss Davanat NDA with FDA
Read More
GS-9137 completes phase II study in HIV
Read More
Devgen awarded grant to support obesity program
Read More
NovoSeven reduces intracerebral bleeding, fails to improve long-term outcomes
Read More
New therapeutic agents for neurological disorders reported in recent patents
Read More
Zonisamide efficacy unclear in essential tremor study
Read More
Hyaluronic acid dermal filler injections stimulate collagen synthesis
Read More
ASCENT results support evaluation of calcitriol/docetaxel in prostate cancer
Read More
Virus-like particle seasonal influenza vaccine induces broad immune responses in vivo
Read More
VMP-001: a novel highly immunogenic vaccine against Plasmodium vivax
Read More
Prolactin promotes CNS remyelination and repair upon neuronal demyelination
Read More
Elan reflects on Q4 progress
Read More
Cymbalta approved for generalized anxiety disorder
Read More
FK-506 Modified Release recommended for approval in Europe
Read More